The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments

Pulmonary hypertension (PH) adds a substantial disease burden, including higher mortality, when associated with interstitial lung disease (ILD), a severe, chronic, progressive condition. Yet little is known of the lived experiences, perspectives, priorities, and viewpoints of patients and carers liv...

Descripción completa

Detalles Bibliográficos
Autores: Piccari, Lucilla, Kovacs, Gabor, Jones, Steve, Skaara, Hall, Roca Herms, Claudia, Bacchini Jeanneret, Gabriela Silvina, Calzado Vinardell, Melquiades, Gonzalez-Rojas Guix, Nuria, Fernandez Delgado, Miriam, Gálvez García, Héctor, 1989-, Schwicker, David
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/70903
Acceso en línea:http://hdl.handle.net/10230/70903
http://dx.doi.org/10.1002/pul2.12405
Access Level:acceso abierto
Palabra clave:Health‐related quality of life
Interstitial lung disease
Patient experience data
Patient‐involvement
Pulmonary hypertension
id ES_c1d04b63ad616d87646cfa037dff00a8
oai_identifier_str oai:repositori.upf.edu:10230/70903
network_acronym_str ES
network_name_str España
repository_id_str
spelling The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatmentsPiccari, LucillaKovacs, GaborJones, SteveSkaara, HallRoca Herms, ClaudiaBacchini Jeanneret, Gabriela SilvinaCalzado Vinardell, MelquiadesGonzalez-Rojas Guix, NuriaFernandez Delgado, MiriamGálvez García, Héctor, 1989-Schwicker, DavidHealth‐related quality of lifeInterstitial lung diseasePatient experience dataPatient‐involvementPulmonary hypertensionPulmonary hypertension (PH) adds a substantial disease burden, including higher mortality, when associated with interstitial lung disease (ILD), a severe, chronic, progressive condition. Yet little is known of the lived experiences, perspectives, priorities, and viewpoints of patients and carers living with PH-ILD. The Voice of the Patient meeting at the center of this qualitative research study aims to provide these difficult-to-obtain insights from a European perspective for the first time. The multistakeholder approach brought together four PH-ILD patients, three primary caregivers, two patient associations, clinical experts, sponsor representatives, and a facilitator. Of the six major themes identified in the thematic analysis, symptoms, and physical limitations were the most impactful. Shortness of breath was the most bothersome symptom affecting patients daily. Further symptoms included fatigue, cough, dizziness, syncope, edema, and palpitations. Physical limitations focused on reduced mobility, impacting patients' ability to perform daily tasks, hobbies, sports, and to enjoy travel. Existing antifibrotic and pulmonary arterial hypertension-targeted treatments were perceived as beneficial. However, despite advances in treatment, severe disease burdens and high unmet medical needs persist from the perspectives of patients. Most meaningful to patients' daily wellbeing was supplemental oxygen, enabling greater mobility. Patients and carers reported difficulties and barriers in navigating the healthcare system and obtaining adequate information to reduce their considerable uncertainties, documenting the substantial challenges that rare and complex conditions such as PH-ILD pose for routine clinical practice beyond PH expert centers and indicating an urgent need for high-quality patient- and clinician-directed information to support patient-centered care.Wiley202520252024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/70903http://dx.doi.org/10.1002/pul2.12405reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésPulm Circ. 2024 Jun 22;14(2):e12405© 2024 The Author(s). Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.http://creativecommons.org/licenses/by-nc/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/709032026-06-12T07:21:37Z
dc.title.none.fl_str_mv The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
title The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
spellingShingle The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
Piccari, Lucilla
Health‐related quality of life
Interstitial lung disease
Patient experience data
Patient‐involvement
Pulmonary hypertension
title_short The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
title_full The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
title_fullStr The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
title_full_unstemmed The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
title_sort The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments
dc.creator.none.fl_str_mv Piccari, Lucilla
Kovacs, Gabor
Jones, Steve
Skaara, Hall
Roca Herms, Claudia
Bacchini Jeanneret, Gabriela Silvina
Calzado Vinardell, Melquiades
Gonzalez-Rojas Guix, Nuria
Fernandez Delgado, Miriam
Gálvez García, Héctor, 1989-
Schwicker, David
author Piccari, Lucilla
author_facet Piccari, Lucilla
Kovacs, Gabor
Jones, Steve
Skaara, Hall
Roca Herms, Claudia
Bacchini Jeanneret, Gabriela Silvina
Calzado Vinardell, Melquiades
Gonzalez-Rojas Guix, Nuria
Fernandez Delgado, Miriam
Gálvez García, Héctor, 1989-
Schwicker, David
author_role author
author2 Kovacs, Gabor
Jones, Steve
Skaara, Hall
Roca Herms, Claudia
Bacchini Jeanneret, Gabriela Silvina
Calzado Vinardell, Melquiades
Gonzalez-Rojas Guix, Nuria
Fernandez Delgado, Miriam
Gálvez García, Héctor, 1989-
Schwicker, David
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Health‐related quality of life
Interstitial lung disease
Patient experience data
Patient‐involvement
Pulmonary hypertension
topic Health‐related quality of life
Interstitial lung disease
Patient experience data
Patient‐involvement
Pulmonary hypertension
description Pulmonary hypertension (PH) adds a substantial disease burden, including higher mortality, when associated with interstitial lung disease (ILD), a severe, chronic, progressive condition. Yet little is known of the lived experiences, perspectives, priorities, and viewpoints of patients and carers living with PH-ILD. The Voice of the Patient meeting at the center of this qualitative research study aims to provide these difficult-to-obtain insights from a European perspective for the first time. The multistakeholder approach brought together four PH-ILD patients, three primary caregivers, two patient associations, clinical experts, sponsor representatives, and a facilitator. Of the six major themes identified in the thematic analysis, symptoms, and physical limitations were the most impactful. Shortness of breath was the most bothersome symptom affecting patients daily. Further symptoms included fatigue, cough, dizziness, syncope, edema, and palpitations. Physical limitations focused on reduced mobility, impacting patients' ability to perform daily tasks, hobbies, sports, and to enjoy travel. Existing antifibrotic and pulmonary arterial hypertension-targeted treatments were perceived as beneficial. However, despite advances in treatment, severe disease burdens and high unmet medical needs persist from the perspectives of patients. Most meaningful to patients' daily wellbeing was supplemental oxygen, enabling greater mobility. Patients and carers reported difficulties and barriers in navigating the healthcare system and obtaining adequate information to reduce their considerable uncertainties, documenting the substantial challenges that rare and complex conditions such as PH-ILD pose for routine clinical practice beyond PH expert centers and indicating an urgent need for high-quality patient- and clinician-directed information to support patient-centered care.
publishDate 2024
dc.date.none.fl_str_mv 2024
2025
2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/70903
http://dx.doi.org/10.1002/pul2.12405
url http://hdl.handle.net/10230/70903
http://dx.doi.org/10.1002/pul2.12405
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Pulm Circ. 2024 Jun 22;14(2):e12405
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by-nc/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869418590825873408
score 15,812429